Literature DB >> 15862587

HIV may produce inhibitory microRNAs (miRNAs) that block production of CD28, CD4 and some interleukins.

Jacob P Couturier1, Robert S Root-Bernstein.   

Abstract

It is well-known that HIV-1 infection results in a gradual decline of the CD4+ T-lymphocytes, but the underlying mechanism of this decline is not completely understood. Research has shown that HIV-1 infection of CD4+ T cells results in decreased CD28 expression, but the mechanism of this repression is unknown. There is also substantial evidence demonstrating regulatory involvement of microRNA (miRNA) during protein expression in plants and some animals, and reports have recently been published confirming the existence of viral-encoded miRNAs. Based on these findings, we hypothesize that viral-encoded miRNA from HIV-1 may directly alter T cell, macrophage and dendritic cell activity. To investigate a potential correlation between the genomic complementarity of HIV-1 and host cell protein expression, a local alignment search was performed to assess for regions of complementarity between the HIV-1 proviral genome and the mRNA coding sequence of various proteins expressed by CD+ T cells and macrophages. Regions of complementarity with strong correlations to the currently established criteria for miRNA:target mRNA activity were found between HIV-1 and CD28, CTLA-4 and some interleukins, suggesting that HIV-1 may produce translational repression in host cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15862587     DOI: 10.1016/j.jtbi.2005.01.001

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  16 in total

Review 1.  Noncoding RNPs of viral origin.

Authors:  Joan Steitz; Sumit Borah; Demian Cazalla; Victor Fok; Robin Lytle; Rachel Mitton-Fry; Kasandra Riley; Tasleem Samji
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-03-01       Impact factor: 10.005

2.  Are viral-encoded microRNAs mediating latent HIV-1 infection?

Authors:  Marc S Weinberg; Kevin V Morris
Journal:  DNA Cell Biol       Date:  2006-04       Impact factor: 3.311

Review 3.  Concise review: MicroRNA expression in multipotent mesenchymal stromal cells.

Authors:  Uma Lakshmipathy; Ronald P Hart
Journal:  Stem Cells       Date:  2007-11-08       Impact factor: 6.277

Review 4.  Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs.

Authors:  Mayte Coiras; María Rosa López-Huertas; Mayte Pérez-Olmeda; José Alcamí
Journal:  Nat Rev Microbiol       Date:  2009-11       Impact factor: 60.633

Review 5.  Host-virus interaction: a new role for microRNAs.

Authors:  Vinod Scaria; Manoj Hariharan; Souvik Maiti; Beena Pillai; Samir K Brahmachari
Journal:  Retrovirology       Date:  2006-10-11       Impact factor: 4.602

6.  Prediction of viral microRNA precursors based on human microRNA precursor sequence and structural features.

Authors:  Shiva Kumar; Faraz A Ansari; Vinod Scaria
Journal:  Virol J       Date:  2009-08-20       Impact factor: 4.099

7.  Oncoviruses and Pathogenic MicroRNAs in Humans.

Authors:  Yoichi Robertus Fujii
Journal:  Open Virol J       Date:  2009-05-07

Review 8.  Interfering RNA and HIV: reciprocal interferences.

Authors:  Pierre Corbeau
Journal:  PLoS Pathog       Date:  2008-09-26       Impact factor: 6.823

Review 9.  Silencing viral microRNA as a novel antiviral therapy?

Authors:  Ugo Moens
Journal:  J Biomed Biotechnol       Date:  2009-05-28

10.  HIV-1 TAR element is processed by Dicer to yield a viral micro-RNA involved in chromatin remodeling of the viral LTR.

Authors:  Zachary Klase; Prachee Kale; Rafael Winograd; Madhur V Gupta; Mohammad Heydarian; Reem Berro; Timothy McCaffrey; Fatah Kashanchi
Journal:  BMC Mol Biol       Date:  2007-07-30       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.